Wellington Shields Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$839K Sell
6,974
-129
-2% -$14.9K 0.13% 119
2025
Q4
$748K Sell
7,103
-332
-4% -$31.2K 0.11% 127
2025
Q3
$624K Sell
7,435
-2,499
-25% -$206K 0.09% 135
2025
Q2
$786K Sell
9,934
-1,499
-13% -$119K 0.13% 120
2025
Q1
$1.03M Sell
11,433
-145,719
-93% -$13.6M 0.19% 97
2024
Q4
$938K Buy
157,152
+145,250
+1,220% +$15M 0.17% 104
2024
Q3
$1.35M Buy
11,902
+301
+3% +$35.8K 0.23% 89
2024
Q2
$1.44M Buy
11,601
+230
+2% +$29.6K 0.26% 83
2024
Q1
$1.5M Buy
11,371
+100
+0.9% +$12.3K 0.28% 78
2023
Q4
$1.23M Hold
11,271
0.15% 95
2023
Q3
$1.16M Hold
11,271
0.15% 91
2023
Q2
$1.3M Buy
11,271
+470
+4% +$53.4K 0.16% 85
2023
Q1
$1.15M Buy
10,801
+30
+0.3% +$3.24K 0.14% 89
2022
Q4
$1.2M Hold
10,771
0.15% 88
2022
Q3
$928K Hold
10,771
0.22% 104
2022
Q2
$982K Hold
10,771
0.12% 100
2022
Q1
$884K Sell
10,771
-8,000
-43% -$631K 0.1% 126
2021
Q4
$1.44M Buy
18,771
+9,687
+107% +$772K 0.18% 111
2021
Q3
$682K Sell
9,084
-15,354
-63% -$1.17M 0.09% 152
2021
Q2
$1.9M Sell
24,438
-66,539
-73% -$4.95M 0.23% 89
2021
Q1
$6.69M Buy
90,977
+63,771
+234% +$4.7M 0.64% 32
2020
Q4
$2.12M Buy
27,206
+17,477
+180% +$1.34M 0.28% 77
2020
Q3
$770K Sell
9,729
-8,969
-48% -$703K 0.12% 119
2020
Q2
$1.38M Sell
18,698
-10,227
-35% -$770K 0.22% 86
2020
Q1
$2.12M Buy
28,925
+8,417
+41% +$662K 0.4% 57
2019
Q4
$1.78M Buy
20,508
+220
+1% +$18.1K 0.27% 83
2019
Q3
$1.63M Buy
20,288
+3,723
+22% +$298K 0.27% 81
2019
Q2
$1.32M Buy
16,565
+542
+3% +$41.5K 0.22% 93
2019
Q1
$1.27M Buy
16,023
+2,411
+18% +$180K 0.22% 95
2018
Q4
$992K Sell
13,612
-647
-5% -$45.7K 0.19% 115
2018
Q3
$965K Sell
14,259
-302
-2% -$19.2K 0.16% 136
2018
Q2
$843K Sell
14,561
-18,204
-56% -$1.03M 0.14% 144
2018
Q1
$1.7M Sell
32,765
-209
-0.6% -$11.3K 0.26% 90
2017
Q4
$1.77M Sell
32,974
-3,254
-9% -$180K 0.27% 82
2017
Q3
$2.21M Sell
36,228
-2,306
-6% -$140K 0.36% 60
2017
Q2
$2.36M Sell
38,534
-1,153
-3% -$70.2K 0.38% 57
2017
Q1
$2.41M Buy
39,687
+577
+1% +$35K 0.39% 54
2016
Q4
$2.2M Sell
39,110
-14,044
-26% -$822K 0.36% 61
2016
Q3
$3.17M Buy
53,154
+5,083
+11% +$297K 0.55% 41
2016
Q2
$2.64M Sell
48,071
-3,668
-7% -$195K 0.45% 50
2016
Q1
$2.61M Buy
51,739
+1,689
+3% +$82.7K 0.46% 49
2015
Q4
$2.52M Buy
50,050
+1,362
+3% +$68.7K 0.43% 49
2015
Q3
$2.29M Sell
48,688
-20,214
-29% -$1.07M 0.4% 48
2015
Q2
$3.74M Sell
68,902
-105
-0.2% -$5.89K 0.57% 38
2015
Q1
$3.79M Sell
69,007
-629
-0.9% -$35.6K 0.57% 34
2014
Q4
$3.77M Sell
69,636
-524
-0.7% -$29.2K 0.6% 32
2014
Q3
$3.97M Sell
70,160
-906
-1% -$50.9K 0.66% 26
2014
Q2
$3.92M Buy
71,066
+19,211
+37% +$1.05M 0.61% 28
2014
Q1
$2.81M Sell
51,855
-3,509
-6% -$182K 0.48% 34
2013
Q4
$2.64M Sell
55,364
-376
-0.7% -$17.2K 0.47% 35
2013
Q3
$2.53M Buy
55,740
+4,529
+9% +$207K 0.48% 32
2013
Q2
$2.27M Buy
+51,211
New +$2.29M 0.4% 39

Other funds holding MRK

Wellington Shields Capital Management's MRK Position: Q1 2026 in Review

Wellington Shields Capital Management reduced its Merck (MRK) stake by 1.8% in Q1 2026, selling an estimated $14.9K and leaving 6,974 shares worth $839K. The position accounts for 0.13% of the portfolio, ranked #119.

Wellington Shields Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.69M in Q1 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wellington Shields Capital Management held 6,974 shares of Merck worth $839K as of Q1 2026.
  • Wellington Shields Capital Management sold 129 Merck shares in Q1 2026, an estimated $14.9K.
  • Merck made up 0.13% of Wellington Shields Capital Management's portfolio in Q1 2026, its #119 holding.
  • Wellington Shields Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Wellington Shields Capital Management's Merck position peaked at $6.69M in Q1 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.